Investigating the Impact of METTL3 on Reinforcing Cell Adhesion by Enhancing Immunity through m6A-Mediated Stabilization of Integrin β1 mRNA in Osteosarcoma
DOI:
https://doi.org/10.64229/950cwp20Keywords:
METTL3, Osteosarcoma M6A, Anti-tumor, ITGB1, Cell adhesionAbstract
Osteosarcoma, a prevalent primary malignancy, continues to present significant challenges for current treatment strategies. However, a promising breakthrough emerges with PR-619, a novel inhibitor of deubiquitinating enzymes, showcasing remarkable anti-tumor effectiveness across various cancers. Recent advances in N6-methyladenosine (m6A) mRNA methylation reveal its critical role in human diseases, notably cancer. In our investigation, we've unveiled heightened METTL3 (Methyltransferase 3 (N6-Adenosine-Methyltransferase Complex Catalytic Subunit)) expression was identified in osteosarcoma, particularly in cases with bone metastasis, and was significantly associated with advanced disease progression and poor prognosis. Functional analyses demonstrated that METTL3, through an m6A-HuR-dependent mechanism, regulates Integrin β1 (ITGB1) expression, thereby enhancing its interaction with Collagen I and promoting osteosarcoma cell adhesion and motility, ultimately facilitating bone metastasis. Notably, METTL3-ITGB1-mediated adhesion remodeling may also influence immune-tumor interactions within the bone tumor microenvironment by altering extracellular matrix dynamics and immune cell accessibility. These findings elucidate a previously unrecognized epitranscriptomic mechanism underlying osteosarcoma metastasis and highlight METTL3 as a potential therapeutic target warranting further investigation with potential implications for potential effects on the tumor microenvironment that require future investigation.
References
[1]Ritter J, Bielack SS. Osteosarcoma. Annals of Oncology, 2010, 21(7), vii320-vii325. DOI: 10.1093/annonc/mdq276
[2]Liu JF, Shanmugavadivel D, Ball-Gamble A, Walker D. Clinical presentation of bone tumours in children and young people: A systematic review and meta-analysis. Archives of Disease in Childhood, 2025, 110(8), 622-629. DOI: 10.1136/archdischild-2024-327879
[3]Hosseini H, Heydari S, Hushmandi K, Daneshi S, Raesi R. Bone tumors: A systematic review of prevalence, risk determinants, and survival patterns. BMC Cancer, 2025, 25(1), 321. DOI: 10.1186/s12885-025-13720-0
[4]Iacobellis G, Leggio A, Salzillo C, Lucà S, Ortega-Ruiz R, Marzullo A. Analysis and historical evolution of paediatric bone tumours: The importance of early diagnosis in the detection of childhood skeletal malignancies. Cancers, 2025, 17(3), 451. DOI: 10.3390/cancers17030451
[5]Biermann JS, Hirbe A, Ahlawat S, Bernthal NM, Binitie O, Boles S. Bone cancer, version 2.2025, NCCN clinical practice guidelines in oncology. Journal of The National Comprehensive Cancer Network, 2025, 23(4), 1-21. DOI: 10.6004/jnccn.2025.0017
[6]Vignati G, Zantonelli G, Albano D, Gitto S, Sconfienza LM. Introduction to malignant bone tumors: Clinical presentation and diagnostic imaging. Malignant Bone Lesions and Beyond, 2025, 1-16. DOI: 10.1007/978-3-032-00018-7_1
[7]Zheng BX, Sun XC, Zhang L, Qu GJ, Ren CM, Yan P. Inhibition of anlotinib-induced autophagy attenuates invasion and migration by regulating epithelial-mesenchymal transition and cytoskeletal rearrangement through ATG5 in human osteosarcoma cells. Brazilian Journal of Medical and Biological Research, 2024, 57, e13152. DOI: 10.1590/1414-431X2023e13152
[8]Lindsey BA, Markel JE, Kleinerman ES. Osteosarcoma overview. Rheumatology and Therapy, 2017, 4, 25-43. DOI: 10.1007/s40744-016-0050-2
[9]Maden BEH. The numerous modified nucleotides in eukaryotic ribosomal RNA. Progress in Nucleic Acid Research and Molecular Biology, 1990, 39, 241-303. DOI: 10.1016/S0079-6603(08)60629-7
[10]Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma HH, et al. N6-methyladenosine modulates messenger RNA translation efficiency. Cell, 2015, 161(6), 1388-1399. DOI: 10.1016/j.cell.2015.05.014
[11]Wang X, Lu Z, Gomez A, Hong GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature, 2013, 505, 117-120. DOI: 10.1038/nature12730
[12]Geuens T, Bouhy D, Timmerman V. The hnRNP family: Insights into their role in health and disease. Human Genetics, 2016, 135, 851-867. DOI: 10.1007/s00439-016-1683-5
[13]Xiao YL, Chen J, Zhou H, Zeng XD, Ruan ZP, Pu ZY, et al. Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy. Nature Communications, 2022, 13, 758. DOI: 10.1038/s41467-022-28279-8
[14]Wang CB, He Y, Zheng J, Wang X, Chen SH. Dissecting order amidst chaos of programmed cell deaths: Construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment. Frontiers in Immunology, 2023, 14, 1130513. DOI: 10.3389/fimmu.2023.1130513
[15]Agris PF, Vendeix FAP, Graham WD. tRNA’s wobble decoding of the genome: 40 years of modification. Journal of Molecular Biology, 2007, 366(1), 1-13. DOI: 10.1016/j.jmb.2006.11.046
[16]Dai DJ, Wang HY, Zhu LY, et al. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death & Disease, 2018, 9, 124. DOI: 10.1038/s41419-017-0129-x
[17]Manzoor U, Ali A, Ali SL, Abdelkarem O, Kanwal S, Alotaibi SS, et al. Mutational screening of GDAP1 in dysphonia associated with charcot-marie-tooth disease: Clinical insights and phenotypic effects. Journal of Genetic Engineering and Biotechnology, 2023, 21(1), 119. DOI: 10.1186/s43141-023-00568-9
[18]Aiman S, Ahmad A, Khan AA, Alanazi AM, Samad A, Ali SL, et al. Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica-A hierarchical subtractive proteomics and immunoinformatics approach. Frontiers in Immunology, 2023, 14, 1259612. DOI: 10.3389/fimmu.2023.1259612
[19]Yi L, Zheng C. Dual-luciferase reporter assay to investigate virus-host interactions. Molecular Virology, 2025, 337-341. DOI: 10.1007/978-1-0716-4615-1_29
[20]Yao N, Zhou J, Jiang Y, Jin QM, Zhu H, Zhang J, et al. Rhizoma Paridis saponins suppresses vasculogenic mimicry formation and metastasis in osteosarcoma through regulating miR-520d-3p/MIG-7 axis. Journal of Pharmacological Sciences, 2022, 150(3), 180-190. DOI: 10.1016/j.jphs.2022.08.005
[21]Yao N, Zhou J, Jiang Y, Jin QM, Zhu H, Zhang J, et al. Rhizoma Paridis saponins suppresses vasculogenic mimicry formation and metastasis in osteosarcoma through regulating miR-520d-3p/MIG-7 axis. Journal of Pharmacological Sciences, 2022, 150(3), 180-190. DOI: 10.1016/j.jphs.2022.08.005
[22]Wang H, Zuo HN, Liu J, Wen F, Gao YW, Zhu XD, et al. Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration. Cell Research, 2018, 28, 1035-1038. DOI: 10.1038/s41422-018-0082-y
[23]Hall CL, Dai JL, van Golen KL, Keller ET, Long MW. Type I collagen receptor (α2β1) signaling promotes the growth of human prostate cancer cells within the bone. Cancer Research, 2006, 66(17), 8648-8654. DOI: 10.1158/0008-5472.CAN-06-1544
[24]Zhu JJ, Ye ZJ, Zhang Z, Liu JY, Ali SL. AI-integrated 3D imaging and modelling for hip morphology assessment in athletes. Computer Methods in Biomechanics and Biomedical Engineering, 2025, 1-11. DOI: 10.1080/10255842.2025.2502828
[25]Li H, Guan KF, Liu DD, Liu M. Identification of mitochondria-related hub genes in sarcopenia and functional regulation of MFG-E8 on ROS-mediated mitochondrial dysfunction and cell cycle arrest. Food Funct, 2022, 13(2), 624-638. DOI: 10.1039/d1fo02610k
[26]Getachew N, Meten M. Weights of evidence modeling for landslide susceptibility mapping of Kabi-Gebro locality, Gundomeskel area, Central Ethiopia. Geoenvironmental Disasters, 2021, 8, 6. DOI: 10.1186/s40677-021-00177-z
[27]Ali SL, Ali A, Khan A. Identification and assessment of ferroptosis-related genes and their implication as therapeutic agents for pancreatic ductal adenocarcinoma. Annals of Pancreatic Cancer, 2025, 8. DOI: 10.21037/apc-25-2
[28]Li E, Wei B, Wang XL, Kang R. METTL3 enhances cell adhesion through stabilizing integrin β1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma. American Journal of Cancer Research, 2020, 10(3), 1012-1025.
[29]Chen XR, Luo Y, Zhu Q, Zhang JZ, Huang H, Kan YS, et al. Small extracellular vesicles from young plasma reverse age-related functional declines by improving mitochondrial energy metabolism. Nature Aging, 2024, 4, 814-838. DOI: 10.1038/s43587-024-00612-4
[30]Zhuang DX, Wang SS, Liu GY, Liu PP, Deng HT, Sun JF, et al. Phenformin suppresses angiogenesis through the regulation of exosomal microRNA-1246 and microRNA-205 levels derived from oral squamous cell carcinoma cells. Frontiers in Oncology, 2022, 12, 943477. DOI: 10.3389/fonc.2022.943477
[31]Lawrence P, Escudero-Pérez B. Henipavirus immune evasion and pathogenesis mechanisms: lessons learnt from natural infection and animal models. Viruses, 2022, 14(5), 936. DOI: 10.3390/v14050936
[32]Ali A, Ali SL, Ullah W, Khan A. Gene expression profiling identifies CAV1, CD44, and TFRC as potential diagnostic markers and therapeutic targets for multiple myeloma. Cell Biochemistry and Biophysics, 2025, 83, 3633-3650. DOI: 10.1007/s12013-025-01743-0
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Syed Luqman Ali, Awais Ali (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
